Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 5585 (miR-5585) is a short, non-coding RNA molecule of approximately 20-24 nucleotides classified as a microRNA, a family known for regulating the expression of target genes by binding to mRNA and thereby promoting mRNA degradation or inhibiting translation[5][1]. miR-5585-3p can bind to over 600 mRNA targets, with binding sites found in the 3' untranslated region (3' UTR), 5' UTR, and coding sequence regions of diverse genes in human cells[1]. The functional characterization of miR-5585 is limited, but its broad target spectrum suggests a potential role as a coordinator of gene expression in various fundamental cellular processes, similar to other microRNAs[1][2][6]. There is no evidence currently supporting its role as a classical therapeutic target such as a receptor or enzyme, nor are there established drug interactions or biomarker uses specific for miR-5585. The molecule is of scientific interest for its regulatory functions but is not established as a clinical target, biomarker, or safety concern according to available research.
Not applicable (not a therapeutic protein target; no known small-molecule or antibody interactions reported)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 5585 (miR-5585).